FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood-2017-02-767707
Abstract: To the editor: Acute promyelocytic leukemia (APL) is characterized by the promyelocytic leukemia-retinoic acid receptor α ( PML-RARA ) fusion. In rare instances, RARA is fused to other partners, which dictate sensitivity to targeted therapies.… read more here.
Keywords: acute promyelocytic; rara; promyelocytic leukemia; another novel ... See more keywords